12:00 AM
Jan 21, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

DNA/MVA vaccine: Completed Phase I/II enrollment

GeoVax completed enrollment of 9 HIV-infected patients with suppressed viremia who started anti-retroviral (ART) therapy within 18 months of a negative HIV antibody test in the...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >